Joseph L. Savage v. James E. Grimes Jr., Commissioner of Social Security

CourtDistrict Court, N.D. Ohio
DecidedDecember 4, 2025
Docket5:25-cv-00762
StatusUnknown

This text of Joseph L. Savage v. James E. Grimes Jr., Commissioner of Social Security (Joseph L. Savage v. James E. Grimes Jr., Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joseph L. Savage v. James E. Grimes Jr., Commissioner of Social Security, (N.D. Ohio 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

JOSEPH L. SAVAGE, CASE NO. 5:25-cv-762

Plaintiff, MAGISTRATE JUDGE vs. JAMES E. GRIMES JR.

COMMISSIONER OF SOCIAL SECURITY, MEMORANDUM OPINION Defendant. AND ORDER

Plaintiff Joseph L. Savage filed a complaint against the Commissioner of Social Security seeking judicial review of the Commissioner’s decision denying his applications for supplemental security income and disability insurance benefits. Doc. 1. This Court has jurisdiction under 42 U.S.C. §§ 405(g) and 1383(c). The parties consented to my jurisdiction in this case. Doc. 4. Following review, and for the reasons stated below, I affirm the Commissioner’s decision. Procedural Background In November 2022, Savage filed applications for both supplemental security income and disability insurance benefits, alleging a disability onset

date of August 14, 2022.1 Tr. 157–66. In pertinent part, Savage alleged that he was disabled and unable to work due to the following impairments: warm blooded hemolytic anemia, peripheral arterial disease, Type-2 diabetes, and hypertension. Tr. 194. In June 2023, Savage requested a hearing. Tr. 104. Administrative Law Judge (“ALJ”) Mary Lohr held a telephone hearing in February 2024. Tr. 31.

Savage appeared, testified, and was represented by counsel at the February 2024 hearing. Tr. 34. Qualified vocational expert Lynn Smith also testified. Id. In April 2024, the ALJ issued a written decision, which found that Savage was not entitled to benefits. Tr. 14–30. In April 2024, Savage appealed the ALJ’s decision to the Appeals Counsel. Tr. 155. In February 2025, the Appeals Counsel denied Savage’s appeal, making the ALJ’s April 2024 decision the final decision of the

Commissioner. Tr. 1; see 20 C.F.R. § 404.981. Savage timely filed this action in April 2025. Doc. 1. In his opening brief, Savage raises four issues:

1 “Once a finding of disability is made, the [agency] must determine the onset date of the disability.” McClanahan v. Comm’r of Soc. Sec., 193 F. App’x 422, 425 (6th Cir. 2006). 1. The ALJ erred at Step Three of the Sequential Evaluation when she failed to find that Plaintiff satisfied the criteria of Listing 4.12.

2. The ALJ erred when she failed to support her conclusions or discuss supportability and consistency when she evaluated the opinions of the treating sources.

3. The ALJ erroneously failed to comply with Social Security Ruling 16-3p when evaluating the totality of Plaintiff’s symptoms.

4. The ALJ’s finding that Plaintiff did not require the use of a cane for both ambulation and standing was not supported by substantial evidence. Doc. 8, at 1. Evidence The parties do not dispute the ALJ’s description of the medical record, so the ALJ’s summary of the evidence is incorporated as follows: The claimant’s primary health concern is peripheral arterial disease in his legs. The claimant was hospitalized from August 10 through August 17, 2021, after presenting with pain and discoloration in the right great toe (1F1). Diagnostic studies on intake showed near complete occlusion of the right external iliac artery, and severe stenosis of the right SFA and popliteal artery with minimal tibial runoff (1F3). Due to the shown severity of occlusion in the right lower extremity, the claimant had stenting placed therein on August 16, 2021 (1F4). Upon discharge, the claimant was started on a medicinal regime of Plavix and warfarin (2F19).

Generally, the record does not reflect an episode of peripheral arterial disease symptoms as severe as those that led to this hospitalization in August 2021. Diagnostic studies dated December 19, 2022 showed mild arterial occlusive disease in the right lower extremity, and moderate occlusive disease in the left (9F67). A few months later on February 16, 2023, diagnostic studies demonstrated severe atherosclerotic disease in the left external iliac artery, and seventy five percent stenosis in the distal left external iliac artery (9F48-9). These findings led to stenting placed in the left lower extremity (9F48- 9).

Since this stent placement in the left lower extremity, diagnostic imaging of the lower extremities have consistently been negative for findings of occlusive arterial disease. Imaging dated February 20, 2023, June 1, 2023, and December 5, 2023 all showed no evidence of occlusive arterial disease in the bilateral lower extremities (6F5, 9F6, 9F32). These studies indicate that the stent placements in both lower extremities were and remain effective at preventing further acute exacerbations of leg pain, swelling, discoloration, and or sensation loss.

The claimant’s testimony of needing to elevate his legs each day is not consistent with the diagnostic findings showing no lower extremity occlusive disease since February 16, 2023. That claim as it pertains to the right lower extremity in particular is inconsistent with the record dating back to discharge from the hospital on August 17, 2021 because the record shows no recurrent, significant occlusive disease in the right lower extremity since stent placement on August 16, 2021 (9F6, 32, 67, 6F5). Clinical examinations subsequent to the stent placement in the respective legs have generally not shown any recurrent, significant edema in either lower extremity (e.g., 9F444).

The claimant’s ability to engage in weight bearing activity is further complicated by other severe impairments however. Laboratory results have consistently demonstrated findings of anemia (e.g., 6F7). Red and white blood cell counts, along with hemoglobin, and hematocrit have all been low on a consistent basis since the alleged onset date (e.g., 9F4, 8). However, these measures have not been markedly abnormal, often falling just below normal levels (9F4, 8). Thus, I find the claimant’s allegations of anemia related pain and fatigue to be only partially consistent with the record. I note as well that the treatment the claimant has received for this condition has been conservative in nature.

An MRI of the lumbar spine dated September 29, 2023 showed grade 1 anterolisthesis of L4 on L5 with mild to moderate degenerative changes at L3- 4, L4-5, and L5-S1 (9F24). The record does not reflect much follow up concerning treatment for lower back pain however. However, any lower back pain is likely made worse by the presence of obesity, evidenced by a body mass index [BMI] of between thirty and thirty five (e.g., 2F19). While the record does not contain specific signs of complication due to obesity, that impairment plus lower back pain do reasonably relate to his allegations of fatigue and muscle weakness after exertion.

The record also reflects diagnoses for other impairments, including hypertension, hyperlipidemia, and diabetes mellitus. I have considered hypertension and hyperlipidemia as severe in the context of a record that shows arterial occlusion at various points, in the lower extremities. These impairments are further cardiovascular concerns, and likely have played some role in the development of said arterial disease. That said, the record contains little to no objective evidence detailing how hypertension and or hyperlipidemia significantly affect the claimant’s ability to work. I have generally considered them as severe as they related to poor cardiovascular functioning. In terms of diabetes, treatment records do show the claimant’s blood glucose levels remain high, despite his taking metformin (6F5, 2F19).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Chemical Foundation, Inc.
272 U.S. 1 (Supreme Court, 1926)
Mcpherson v. Kelsey
125 F.3d 989 (Sixth Circuit, 1997)
Jimmie L. Howard v. Commissioner of Social Security
276 F.3d 235 (Sixth Circuit, 2002)
Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Debbie Webb v. Commissioner of Social Security
368 F.3d 629 (Sixth Circuit, 2004)
Gary Warner v. Commissioner of Social Security
375 F.3d 387 (Sixth Circuit, 2004)
Robert M. Wilson v. Commissioner of Social Security
378 F.3d 541 (Sixth Circuit, 2004)
Lindsley v. Commissioner of Social Security
560 F.3d 601 (Sixth Circuit, 2009)
Jordan v. Commissioner of Social Security
548 F.3d 417 (Sixth Circuit, 2008)
Bass v. McMahon
499 F.3d 506 (Sixth Circuit, 2007)
Cross v. Commissioner of Social Security
373 F. Supp. 2d 724 (N.D. Ohio, 2005)
Bledsoe v. Barnhart
165 F. App'x 408 (Sixth Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Joseph L. Savage v. James E. Grimes Jr., Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/joseph-l-savage-v-james-e-grimes-jr-commissioner-of-social-security-ohnd-2025.